Lipid nanoparticles (LNPs): Delivering Therapeutics / Drug Formulations
Lipid nanoparticles (LNPs) are a class of nanocarriers that have gained significant attention in recent years due to their ability to effectively deliver various therapeutic molecules, including mRNA, siRNA, and small molecules. These particles are composed of lipid-based components, such as phospholipids, cholesterol, and helper lipids, which self-assemble into spherical structures… Read More
Small Molecule: News & Recent Developments
Small molecules are organic compounds with relatively low molecular weights that interact with biological targets, such as proteins, to exert therapeutic effects. They play a crucial role in drug discovery and development, particularly in the pharmaceutical industry… Read More
Monoclonal Antibody: News & Recent Developments
Monoclonal antibodies are proteins produced by immune cells that can specifically bind to a particular target molecule, such as a protein or a specific part of a cell. They have revolutionized biotechnology and drug development, offering a wide range of applications… Read More
Autologous TCR: News & Recent Developments
Autologous TCRs (T-Cell Receptors) are a type of immunotherapy that harnesses the patient’s own immune system to fight cancer and other diseases. This approach involves isolating T cells from the patient’s blood, engineering them to recognize and attack specific tumor antigens, and then re-infusing them back into the patient… Read More
Antibody-drug conjugate: News & Recent Developments
Antibody-drug conjugates (ADCs) are a type of therapeutic agent that combines the targeting specificity of monoclonal antibodies with the cytotoxic potency of potent small molecules. They are designed to deliver potent drugs directly to cancer cells, minimizing damage to healthy tissues… Read More
Microbiome Therapeutics: News & Recent Developments
Microbiome therapeutics is a rapidly evolving field that focuses on harnessing the power of the human microbiome to treat diseases. The microbiome, consisting of trillions of microorganisms (bacteria, fungi, viruses, and others), plays a crucial role in various bodily functions, including digestion, immunity, and metabolism… Read More
Antisense Oligonucleotide: News & Recent Developments
Antisense oligonucleotides (ASOs) are short, synthetic single-stranded DNA or RNA molecules designed to bind to specific mRNA sequences in cells. By binding to mRNA, ASOs can interfere with gene expression, either by blocking translation or by triggering mRNA degradation. This technology has significant potential applications in biotechnology and medicine… Read More